4//SEC Filing
GRAF FINCKENSTEIN FRIEDRICH 4
Accession 0001104659-25-004204
CIK 0001425205other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 6:00 PM ET
Size
9.7 KB
Accession
0001104659-25-004204
Insider Transaction Report
Form 4
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-14+2,813→ 65,464 total - Tax Payment
Common Stock
2025-01-14$5.89/sh−1,578$9,294→ 63,886 total - Exercise/Conversion
Restricted Stock Units
2025-01-14−2,813→ 0 total→ Common stock (2,813 underlying)
Footnotes (6)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on January 14, 2022, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001782981
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 6:00 PM ET
- Size
- 9.7 KB